20 results
F-1/A
EX-3.1
ORTX
Orchard Therapeutics plc
23 Oct 18
Registration statement (foreign) (amended)
6:15am
authorisation in respect of a conflict of interest shall declare to the Board the nature and extent of his interest in a conflict of interest as soon … to address the conflict of interest together with such additional information as may be requested by the Board.
Any authorisation under this Article
8-K
EX-3.1
ORTX
Orchard Therapeutics plc
19 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:09pm
seeking authorisation in respect of a conflict of interest shall declare to the Board the nature and extent of his interest in a conflict of interest … how to address the conflict of interest together with such additional information as may be requested by the Board.
Any authorisation under
20-F
2018 FY
EX-1.1
ORTX
Orchard Therapeutics plc
22 Mar 19
Annual report (foreign)
8:02am
conflicts of interest.
A Director seeking authorisation in respect of a conflict of interest shall declare to the Board the nature and extent of his … interest in a conflict of interest as soon as is reasonably practicable. The Director shall provide the Board with such details of the matter
10-K
2019 FY
EX-10.15
ORTX
Orchard Therapeutics plc
27 Feb 20
Annual report
4:02pm
the Company’s lawful and reasonable written direction; or (v) the Executive’s conduct which is unlawful, fraudulent, dishonest, creates a conflict of interest … .Commitment to Company; Avoidance of Conflict of Interest. While an employee of the Company, I will devote my full-time efforts to the Company’s business
8-K
EX-10.1
ORTX
Orchard Therapeutics plc
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
or entity onto Company premises or into Company workspaces.
4. Commitment to Company; Avoidance of Conflict of Interest. While an employee … of the Company or his or her designee at such time as any activity of either the Company or another business presents me with a conflict of interest
10-K
EX-10.14
6xahvvihpy47kld
27 Feb 20
Annual report
4:02pm
F-1/A
EX-10.11
fwlqcd3h8
23 Oct 18
Registration statement (foreign) (amended)
6:15am
DEF 14A
rdksl9
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
k7hxc
14 Apr 20
Preliminary proxy
4:46pm
10-Q
EX-10.1
sh3chh3 eoe
7 May 20
Quarterly report
4:03pm
10-K
EX-10.16
ulnhf ihf3ul6hkdd3y
27 Feb 20
Annual report
4:02pm
8-K
EX-10.1
d11v1qs hz4hn4a
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
F-1
EX-10.5
am5wlby
4 Oct 18
Registration statement (foreign)
4:48pm
DRS
EX-10.5
mcrerw rawbvqb5uy
6 Aug 18
Draft registration statement
12:00am
F-1/A
EX-10.5
9qbpz psd
23 Oct 18
Registration statement (foreign) (amended)
6:15am
- Prev
- 1
- Next